Circulating Factors in Nephrotic Syndrome

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIain Bressendorff

About this trial

A prospective observational study to investigate the treatment-associated changes of circulating factors associated with glomerular diseases among patients with de novo nephrotic syndrome admitted to hospital for a kidney biopsy.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Plasma albumin < 36 g/L

Urine protein >3.5 g/day or urine protein/creatinine-ratio (UPCR) > 3.5 or urine albumin/creatinine-ratio (UACR) >2200 mg/g

Planned kidney biopsy

Disqualifiers

Kidney transplant recipient

Previously undergone a kidney biopsy

Unable to understand written information in Danish

Trial design

Treatments tested in this trial

  • Observation

Treatment groups

104 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Iain Bressendorff

Lead sponsor

Herlev Hospital

Sponsor institution